CS270597B2 - Method of tertiary alkylsubstituted naphthyridine and quinoline carboxylic acids production - Google Patents

Method of tertiary alkylsubstituted naphthyridine and quinoline carboxylic acids production Download PDF

Info

Publication number
CS270597B2
CS270597B2 CS877295A CS729587A CS270597B2 CS 270597 B2 CS270597 B2 CS 270597B2 CS 877295 A CS877295 A CS 877295A CS 729587 A CS729587 A CS 729587A CS 270597 B2 CS270597 B2 CS 270597B2
Authority
CS
Czechoslovakia
Prior art keywords
group
oxo
fluoro
dihydro
mmol
Prior art date
Application number
CS877295A
Other languages
Czech (cs)
English (en)
Other versions
CS729587A2 (en
Inventor
Abraham Weber
Daniel Bouzard
Munir Essiz
Cesare Pierre Di
Jean-Pierre Jacquet
Philippe Remuzon
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Priority to CS887400A priority Critical patent/CS270598B2/cs
Publication of CS729587A2 publication Critical patent/CS729587A2/cs
Publication of CS270597B2 publication Critical patent/CS270597B2/cs

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D265/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/281,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/301,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C07D215/56Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/08Bridged systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/08Bridged systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CS877295A 1986-10-08 1987-10-08 Method of tertiary alkylsubstituted naphthyridine and quinoline carboxylic acids production CS270597B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CS887400A CS270598B2 (en) 1986-10-08 1988-11-10 Method of 1-tertiary alkylsubstituted naphthyridine and quinoline carboxylic acids preparation

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US91675286A 1986-10-08 1986-10-08
US9923187A 1987-09-25 1987-09-25

Publications (2)

Publication Number Publication Date
CS729587A2 CS729587A2 (en) 1989-11-14
CS270597B2 true CS270597B2 (en) 1990-07-12

Family

ID=26795810

Family Applications (1)

Application Number Title Priority Date Filing Date
CS877295A CS270597B2 (en) 1986-10-08 1987-10-08 Method of tertiary alkylsubstituted naphthyridine and quinoline carboxylic acids production

Country Status (10)

Country Link
EP (1) EP0266576A3 (de)
CN (1) CN87106925A (de)
CS (1) CS270597B2 (de)
IE (1) IE872696L (de)
IL (1) IL84105A0 (de)
NZ (1) NZ222047A (de)
OA (1) OA08688A (de)
PL (2) PL154473B1 (de)
PT (1) PT85886B (de)
YU (2) YU46079B (de)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5173484A (en) * 1988-02-05 1992-12-22 Bayer Aktiengesellschaft Quinolone- and naphthyridone carboxylic acid derivatives, process for their production, antibacterial compositions and feed additives containing them
US4859776A (en) * 1988-03-11 1989-08-22 Abbott Laboratories (S)-7-(3-aminopyrrolidin-1-yl)-1-(ortho, para-difluorophenyl)-1,4-dihydro-6-fluoro-4-oxo-1,8-naphthyridine-3-carboxylic acid and method for its preparation
CA2001203C (en) * 1988-10-24 2001-02-13 Thomas P. Demuth, Jr. Novel antimicrobial dithiocarbamoyl quinolones
EP0997466A1 (de) * 1988-10-24 2000-05-03 PROCTER & GAMBLE PHARMACEUTICALS, INC. Antimikrobielle Laktamchinolone
FI901201A0 (fi) * 1989-03-13 1990-03-09 Bristol Myers Squibb Co Antibakteriella 5-substituerade 1,4-dihydro-4-oxonaftyridin-3-karboxylatderivat och deras framstaellning.
DE3910920A1 (de) * 1989-04-05 1990-10-11 Bayer Ag Enantiomerenreine 7-(3-amino-1-pyrrolidinyl)-chinolon- und -naphthyridoncarbonsaeuren
EP0525057B1 (de) 1990-04-18 2000-06-14 Procter & Gamble Pharmaceuticals, Inc. Antimikrobielle chinolonyl-lactame
JPH06509792A (ja) * 1991-01-14 1994-11-02 ハンミ藥品工業株式會社 新規なキノロン化合物及びその製造方法
EP0571400A1 (de) * 1991-01-14 1993-12-01 Hanmi Pharmaceutical Co.,Ltd. Neue chinolone und verfahren zu deren herstellung
KR940014395A (ko) * 1992-12-09 1994-07-18 강박광 신규한 퀴놀론 유도체 및 그의 제조방법
KR0148277B1 (ko) * 1993-01-18 1998-11-02 채영복 신규한 플루오르퀴놀론계 유도체 및 그의 제조방법
WO1994025464A1 (en) * 1993-04-24 1994-11-10 Korea Research Institute Of Chemical Technology Novel quinolone carboxylic acid derivatives and process for preparing the same
DK0688772T3 (da) * 1994-06-16 1999-11-01 Lg Chemical Ltd Quinolincarboxylsyrederivater med 7-(4-aminomethyl-3-oxim)-pyrrolidinsubstituenter og fremgangsmåde til deres fremstilling
US20020032216A1 (en) 1997-03-21 2002-03-14 Lg Chemical Ltd. Salt of naphthyridine carboxylic acid derivative
MA24500A1 (fr) 1997-03-21 1998-10-01 Lg Life Sciences Ltd Derive du sel d'acide carboxylique de naphthyridine .
US6316488B1 (en) * 1999-06-17 2001-11-13 Merck & Co., Inc. Antibiotic compound
GB9920917D0 (en) 1999-09-03 1999-11-10 Sb Pharmco Inc Novel process
GB9920919D0 (en) 1999-09-03 1999-11-10 Sb Pharmco Inc Novel compound
SE0003795D0 (sv) 2000-10-20 2000-10-20 Astrazeneca Ab Pharmaceutically useful compounds
WO2003031441A1 (en) * 2001-10-04 2003-04-17 Morphochen Aktiengesellschaft Für Kombinatorische Chemie Multiple action compounds
WO2003031443A1 (de) 2001-10-04 2003-04-17 Morphochem Aktiengesellschaft für kombinatorische Chemie Dual action antibiotics
KR100517638B1 (ko) 2002-04-08 2005-09-28 주식회사 엘지생명과학 게미플록사신 산염의 새로운 제조방법
RU2351335C2 (ru) 2003-04-30 2009-04-10 Морфохем Акциенгезельшафт Фюр Комбинаторише Хеми Применение оксазолидинон-хинолиновых гибридных антибиотиков для лечения сибирской язвы и других инфекций
DE10340485B4 (de) 2003-09-03 2015-05-13 Morphochem AG Aktiengesellschaft für kombinatorische Chemie Verfahren zur Herstellung von Oxazolidinon-Chinolon Hybriden
US8158797B2 (en) 2003-12-18 2012-04-17 Morphochem Aktiengesellschaft Fur Kombinatorische Chemie Oxazolidinone-quinolone hybrid antibiotics
ES2310299T5 (es) 2003-12-18 2014-02-10 Morphochem Aktiengesellschaft für kombinatorische Chemie Antibióticos híbridos a base de oxazolidinona-quinolona
US7563805B2 (en) 2005-05-19 2009-07-21 Daiichi Pharmaceutical Co., Ltd. Tri-, tetra-substituted-3-aminopyrrolidine derivative
US7935725B2 (en) 2007-10-31 2011-05-03 Janssen Pharmaceutica Nv Aryl-substituted bridged or fused diamines as modulators of leukotriene A4 hydrolase
PT2336125E (pt) 2008-04-11 2013-03-18 Janssen Pharmaceutica Nv Tiazolopiridina-2-iloxi-fenil e tiazolopirazin-2-iloxifenil aminas como moduladores de leucotrieno a4 hidrolase
JP5746685B2 (ja) 2009-05-14 2015-07-08 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプJanssen Pharmaceutica Naamloze Vennootschap ロイコトリエンa4加水分解酵素のモジュレーターとしての縮合二環式ヘテロアリール部分を2つ有する化合物
ES2383857B1 (es) * 2010-11-23 2013-05-13 Consejo Superior De Investigaciones Científicas (Csic) Haptenos e inmunoreactivos y su uso en la obtención de anticuerpos de familia e inmunoensayos para quinolonas

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH408036A (de) * 1960-02-17 1966-02-28 Lepetit Spa Verfahren zur Herstellung von 3,8-Diazabicyclo-(3,2,1)-octan-2,4-dionen
DE2808070A1 (de) * 1978-02-24 1979-08-30 Bayer Ag Verfahren zur herstellung von 4-pyridon-3-carbonsaeuren und/oder deren derivaten
GB2093018B (en) * 1979-08-22 1984-09-12 Kyorin Seiyaku Kk 6,8-difluoro-quinoline carboxylic acid derivatives
US4665079A (en) * 1984-02-17 1987-05-12 Warner-Lambert Company Antibacterial agents
US4571396A (en) * 1984-04-16 1986-02-18 Warner-Lambert Company Antibacterial agents
DE3509546A1 (de) * 1985-03-16 1986-09-25 Bayer Ag, 5090 Leverkusen 7-amino-1-(subst.cyclopropyl)-1,4-dihydro-4-oxo-3-chinolincarbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel
US4578473A (en) * 1985-04-15 1986-03-25 Warner-Lambert Company Process for quinoline-3-carboxylic acid antibacterial agents

Also Published As

Publication number Publication date
PT85886A (en) 1987-11-01
YU46079B (sh) 1992-12-21
EP0266576A2 (de) 1988-05-11
YU131088A (en) 1988-12-31
IE872696L (en) 1988-04-08
PL154473B1 (en) 1991-08-30
PT85886B (pt) 1990-07-31
PL268098A1 (en) 1988-09-01
NZ222047A (en) 1991-01-29
CN87106925A (zh) 1988-09-14
CS729587A2 (en) 1989-11-14
EP0266576A3 (de) 1989-03-22
IL84105A0 (en) 1988-03-31
OA08688A (fr) 1989-03-31
PL156484B1 (en) 1992-03-31
YU46112B (sh) 1992-12-21
YU186887A (en) 1988-12-31

Similar Documents

Publication Publication Date Title
CS270597B2 (en) Method of tertiary alkylsubstituted naphthyridine and quinoline carboxylic acids production
DK170404B1 (da) 7-(1-Pyrrolidinyl)-3-quinoloncarboxylsyrederivater, fremgangsmåder og mellemprodukter til deres fremstilling, lægemidler, dyrefoder, dyrefodertilsætningsmidler og forblandinger indeholdende derivaterne og anvendelse af derivaterne til fremstilling af lægemidler og som dyrefodertilsætningsmidler
DK173057B1 (da) 5-Alkyl-6-fluor-1,4-dihydro-4-oxo-1,8-naphthyridinforbindelser, fremgangsmåder til fremstilling deraf, farmaceutisk præpara
DK172152B1 (da) Quinolon- og naphthyridinderivater
CZ667886A3 (en) Substituted bridged diazabicycloalkyl quinolonecarboxylic acids, process of their preparation and pharmaceutical compositions in which they are contained
Bouzard et al. Fluoronaphthyridines and quinolones as antibacterial agents. 2. Synthesis and structure-activity relationships of new 1-tert-butyl 7-substituted derivatives
US5091384A (en) Anti-bacterial quinolone- and naphthyridone-carboxylic acid compounds
US4954507A (en) 1-tertiary-alkyl-substituted naphthyridine carboxylic acid antibacterial agents
SK285223B6 (sk) Deriváty kyseliny chinolónkarboxylovej a naftyridónkarboxylovej, spôsob ich výroby, liečivá tieto látky obsahujúce a ich použitie
CS246065B2 (en) Method of new 7-substituted cyclic aminonaphthyridine-,quinoline-and benzoxazinecarboxylic acids production
AU611400B2 (en) 1-tertiary-alkyl-substituted naphthyridine-and quinoline-carboxylic acid antibacterial agents
JPS62169789A (ja) 7−(アザビシクロアルキル)−キノロンカルボン酸及び−ナフチリドンカルボン酸誘導体
KR0136792B1 (ko) 퀴놀론 카르복실산 유도체, 그 제조 방법, 이 화합물을 함유하는 향균제
US4965273A (en) Certain 1-tertiary-butyl-naphthyridone carboxylic acid derivatives anti-bacterial agents
JPH04502317A (ja) 抗菌性キノロン化合物
US4923879A (en) 1,8-Naphthyridines and their use as antibacterial agents
SK280877B6 (sk) Deriváty kyseliny chinolónkarboxylovej a naftyridónkarboxylovej, spôsob ich výroby, liečivá tieto látky obsahujúce a ich použitie
EP0424852A1 (de) Diazabicycloamin-Verbindungen und Verfahren zu ihrer Herstellung
US4962108A (en) Antibacterial quinoline compounds
AU668286B2 (en) Diazabicyclo(4.3.0)nonane and (3.3.0)octane heterocycles
JPH07300472A (ja) 新規キノロンカルボン酸誘導体およびその製造方法
US4992546A (en) Process for preparing 6,8-diazabicyclo[3.2.2]nonane derivatives
US4968799A (en) Antibacterial agents
JPH0348682A (ja) ピリドンカルボン酸化合物
IE84193B1 (en) 7-(1-Pyrrolidinyl)-3-quinolone and naphthyridone carboxylic acid derivatives, method for their preparation and for substituted mono- and bicyclic pyrrolidine intermediates, and their antibacterial and feed additive compositions